220 related articles for article (PubMed ID: 21321603)
41. Autophagy-dependent ferroptosis contributes to cisplatin-induced hearing loss.
Jian B; Pang J; Xiong H; Zhang W; Zhan T; Su Z; Lin H; Zhang H; He W; Zheng Y
Toxicol Lett; 2021 Oct; 350():249-260. PubMed ID: 34302894
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of Protein arginine methyltransferase 6 reduces reactive oxygen species production and attenuates aminoglycoside- and cisplatin-induced hair cell death.
He Y; Li W; Zheng Z; Zhao L; Li W; Wang Y; Li H
Theranostics; 2020; 10(1):133-150. PubMed ID: 31903111
[TBL] [Abstract][Full Text] [Related]
43. 1,25-dihydroxyvitamin D
Ysmail-Dahlouk L; Nouari W; Aribi M
Immunol Lett; 2016 Nov; 179():122-130. PubMed ID: 27717877
[TBL] [Abstract][Full Text] [Related]
44. siRNA-loaded biodegradable nanocarriers for therapeutic MAPK1 silencing against cisplatin-induced ototoxicity.
Youm I; West MB; Li W; Du X; Ewert DL; Kopke RD
Int J Pharm; 2017 Aug; 528(1-2):611-623. PubMed ID: 28627458
[TBL] [Abstract][Full Text] [Related]
45. Activation of NLRX1-mediated autophagy accelerates the ototoxic potential of cisplatin in auditory cells.
Yin H; Yang Q; Cao Z; Li H; Yu Z; Zhang G; Sun G; Man R; Wang H; Li J
Toxicol Appl Pharmacol; 2018 Mar; 343():16-28. PubMed ID: 29454061
[TBL] [Abstract][Full Text] [Related]
46. Stat4 and Stat6 signaling in hepatic ischemia/reperfusion injury in mice: HO-1 dependence of Stat4 disruption-mediated cytoprotection.
Shen XD; Ke B; Zhai Y; Gao F; Anselmo D; Lassman CR; Busuttil RW; Kupiec-Weglinski JW
Hepatology; 2003 Feb; 37(2):296-303. PubMed ID: 12540779
[TBL] [Abstract][Full Text] [Related]
47. T cell signal transducer and activator of transcription (STAT) 4 and 6 are affected by adalimumab therapy in rheumatoid arthritis.
Aerts NE; Ebo DG; Bridts CH; Stevens WJ; De Clerck LS
Clin Exp Rheumatol; 2010; 28(2):208-14. PubMed ID: 20483042
[TBL] [Abstract][Full Text] [Related]
48. The susceptibility to experimental myasthenia gravis of STAT6-/- and STAT4-/- BALB/c mice suggests a pathogenic role of Th1 cells.
Wang W; Ostlie NS; Conti-Fine BM; Milani M
J Immunol; 2004 Jan; 172(1):97-103. PubMed ID: 14688314
[TBL] [Abstract][Full Text] [Related]
49. STK33 alleviates gentamicin-induced ototoxicity in cochlear hair cells and House Ear Institute-Organ of Corti 1 cells.
Zhou M; Sun G; Zhang L; Zhang G; Yang Q; Yin H; Li H; Liu W; Bai X; Li J; Wang H
J Cell Mol Med; 2018 Nov; 22(11):5286-5299. PubMed ID: 30256516
[TBL] [Abstract][Full Text] [Related]
50. The monofunctional platinum(II) compounds, phenanthriplatin and pyriplatin, modulate apoptosis signaling pathways in HEI-OC1 auditory hybridoma cells.
Monroe JD; Johnston AM; Smith ME
Neurotoxicology; 2020 Jul; 79():104-109. PubMed ID: 32413439
[TBL] [Abstract][Full Text] [Related]
51. Attenuation of cisplatin ototoxicity by otoprotective effects of nanoencapsulated curcumin and dexamethasone in a guinea pig model.
Salehi P; Akinpelu OV; Waissbluth S; Peleva E; Meehan B; Rak J; Daniel SJ
Otol Neurotol; 2014 Aug; 35(7):1131-9. PubMed ID: 24841915
[TBL] [Abstract][Full Text] [Related]
52. miR214-regulated p53-NOX4/p66shc pathway plays a crucial role in the protective effect of Ginkgolide B against cisplatin-induced cytotoxicity in HEI-OC1 cells.
Ma W; Li J; Hu J; Cheng Y; Wang J; Zhang X; Xu M
Chem Biol Interact; 2016 Feb; 245():72-81. PubMed ID: 26768586
[TBL] [Abstract][Full Text] [Related]
53. Interleukin-4 induction of the CC chemokine TARC (CCL17) in murine macrophages is mediated by multiple STAT6 sites in the TARC gene promoter.
Liddiard K; Welch JS; Lozach J; Heinz S; Glass CK; Greaves DR
BMC Mol Biol; 2006 Nov; 7():45. PubMed ID: 17134490
[TBL] [Abstract][Full Text] [Related]
54. 2,2',4,4'-Tetrabromodiphenyl ether (BDE-47) activates Aryl hydrocarbon receptor (AhR) mediated ROS and NLRP3 inflammasome/p38 MAPK pathway inducing necrosis in cochlear hair cells.
Tang J; Hu B; Zheng H; Qian X; Zhang Y; Zhu J; Xu G; Chen D; Jin X; Li W; Xu L
Ecotoxicol Environ Saf; 2021 Sep; 221():112423. PubMed ID: 34146985
[TBL] [Abstract][Full Text] [Related]
55. Protective effect of silymarin against cisplatin-induced ototoxicity.
Cho SI; Lee JE; Do NY
Int J Pediatr Otorhinolaryngol; 2014 Mar; 78(3):474-8. PubMed ID: 24434130
[TBL] [Abstract][Full Text] [Related]
56. NLRX1 accelerates cisplatin-induced ototoxity in HEI-OC1 cells via promoting generation of ROS and activation of JNK signaling pathway.
Yin H; Sun G; Yang Q; Chen C; Qi Q; Wang H; Li J
Sci Rep; 2017 Mar; 7():44311. PubMed ID: 28287190
[TBL] [Abstract][Full Text] [Related]
57. Necroptosis and Apoptosis Contribute to Cisplatin and Aminoglycoside Ototoxicity.
Ruhl D; Du TT; Wagner EL; Choi JH; Li S; Reed R; Kim K; Freeman M; Hashisaki G; Lukens JR; Shin JB
J Neurosci; 2019 Apr; 39(15):2951-2964. PubMed ID: 30733218
[TBL] [Abstract][Full Text] [Related]
58. The STAT4 and STAT6 pathways in pancreatitis-associated lung injury.
Simovic MO; Ballard BR; Gray KD; Stain SC
J Surg Res; 2007 Jan; 137(1):10-5. PubMed ID: 17109890
[TBL] [Abstract][Full Text] [Related]
59. Trehalose protects against cisplatin-induced cochlear hair cell damage by activating TFEB-mediated autophagy.
Li Z; Yao Q; Tian Y; Jiang Y; Xu M; Wang H; Xiong Y; Fang J; Lu W; Yu D; Shi H
Biochem Pharmacol; 2022 Mar; 197():114904. PubMed ID: 34971589
[TBL] [Abstract][Full Text] [Related]
60. The comparative effects of sodium thiosulfate, diethyldithiocarbamate, fosfomycin and WR-2721 on ameliorating cisplatin-induced ototoxicity.
Church MW; Kaltenbach JA; Blakley BW; Burgio DL
Hear Res; 1995 Jun; 86(1-2):195-203. PubMed ID: 8567417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
